Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: Alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44

Blood

Volumn 87, Issue 5, 1996, Pages 1891-1899

  Masellis Smith, A ^b   Belch, A R ^b   Mant, M J ^b   Turley, E A ^b   Pilarski, L M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030045099     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1891.bloodjournal8751891     Document Type: Article

References (46)

1. Hynes RO, Lander AD: Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons Cell 68:303, 1992
2. Juliana RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 120:577, 1993
3. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301, 1994
4. Bernstein LR, Liotta LA: Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 6:106, 1994
5. Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993
6. Dreyfus F, Melle J, Quarre C, Pillier C: Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high dose chemotherapy. Br J Haematol 85:411, 1993
7. + peripheral blood cells expressing CD38, CD56 and monotypic immunoglobulin light chain. Blood 85:436, 1995
8. Pilarski LM, Belch AR: Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma; Implications for treatment. Leuk Lymph 17:367, 1995
9. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
10. Pilarski LM, Belch AR: Circulating monoclonal B cells expressing P-glycoprotein may be a reservoir of multidrug resistant disease in multiple myeloma. Blood 83:724, 1994
11. Pilarski LM, Mant MJ, Belch AR: Circulating monoclonal, multi-drug resistant B cells may comprise the malignant stem cell population in multiple myeloma, in Dammaco F, Barlogie B (eds): Challenges in Modern Medicine, vol 4. Rome, Italy, Ares Sereno Symposia Publications, 1994, p 31
12. Jensen GS, Belch AR, Mant MJ, Ruether BA, Yacyshyn BR, Pilarski LM: Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am J Hematol 43:29, 1992
13. Pilarski LM, Jensen GS: Expression of CD45 isoforms (leukocyte common antigen) and adhesion molecules during normal and abnormal B lymphocyte development. Adv Mol Cell Immunol 1B:75, 1993
14. Jensen GS, Belch AR, Kherani F, Mant MJ, Ruether BA, Pilarski LM: Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scand J Immunol 36:843, 1992
15. Laurent TC, Fraser JRE: Hyaluronan. FASEB J 6:2397, 1992
16. Sherman L, Sleeman J, Herrlich P, Ponta H: Hyaluronate receptors: Key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6:726, 1994
17. Zhang L, Underhill CB, Chen L: Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55:428, 1995
18. Hamann KJ, Dowling TL, Neeley SP, Grant JA, Leff AR: Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol 154:4073, 1995
19. Aruffo A, Stamenkovic I, Meninick M, Underhill CB, Seed B: CD44 is the principle cell surface receptor for hyaluronate. Cell 61:1303, 1990
20. Miyake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69, 1990
21. Lesley J, Hyman R: CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22:2719, 1992
22. Goldstein LA, Zhou DHF, Picker LJ, Minty CN, Bargatze RF, Ding JF, Butcher EC: A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56:1063, 1989
23. Nishina H, Inageda K, Takahashi K, Hoshino S, Ikeda K, Katada T: Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity. Biochem Biophys Res Commun 203:1318, 1994
24. McCourt PAG, Ek B, Forsberg N, Gustafson S: Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269:30081, 1994
25. Yang B, Zhang L, Turley EA: Identification of hyaluronan binding motifs in a novel hyaluronan binding receptor termed RHAMM. J Biol Chem 268:8617, 1993
26. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA: Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117:1343, 1992
27. Hall CL, Wang C, Lange L, Turley EA: Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 126.157, 1994
28. Turley EA, Austin L, Vandligt K, Clary C: Hyaluronan and a cell associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol 112:1041, 1991
29. Pilarski LM, Masellis-Smith A, Belch AR, Yang B, Savani RC, Turley EA: RHAMM, a receptor for hyaluronan-mediated motility, on normal lymphocytes, thymocytes and in B cell malignancy: A mediator in B cell malignancy? Leuk Lymph 14:363, 1994
30. Holmes K, Foulkes BJ: FITC labelling, in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology, vol 1, suppl 1. New York, NY, Green Publishing Associates and Wiley Interscience, p 5
31. Turley EA, Belch AR, Poppema S, Pilarksi LM: Expression and function of a receptor for hyaluronan-mediated motility (RHAMM) on normal and malignant B lymphocytes. Blood 81:446, 1993
32. Hamilton M, Ball J, Bromidge E, Franklin IM: Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. Br J Haematol 78:60, 1991
33. Kim I, Uchiyama H, Chauhan D, Anderson KC: Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br J Haematol 87:483, 1994
34. Dougherty GJ, Cooper DL, Memory JF, Chiu RK: Ligand binding specificity of alternatively spliced CD44 isoforms: Recognition and binding of hyaluronan by CD44R1. J Biol Chem 269:9074, 1994
35. St. Jacques S, Dadi HK, Letarte M: CD44 in human placenta: Localization and binding to hyaluronic acid. Placenta 14:25, 1993
36. Jacobson KJ, O'Dell D, Holifield B, Murphy TL, August JT: Redistribution of a major cell surface glycoprotein during cell movement. J Cell Biol 99:1613, 1984
37. Rosenman SJ, Ganji AA, Tedder TF, Gallatin WM: Syncapping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells. J Leuk Biol 53:1, 1992
38. Turley EA, Torrance J: Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res 161:17, 1985
39. Lesley J, He Q, Kensuke M, Hamann A, Hyman R, Kincade PW: Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. J Exp Med 175:257
40. Lesley J, Howes N, Perschl A, Hyman R: Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med 180:383, 1994
41. Mutakami S, Miyake K, Abe R, Kincade PW, Hodes RJ: Characterization of auto-antibody secreting B cells in mice undergoing stimulatory (chronic) GVH reactions: Identification of a CD44 hi population that binds specifically to hyaluronate. J Immunol 146:1422, 1991
42. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 89:12160, 1992
43. Entwistle J, Zhang S, Yang B, Wong C, Hall CL, Curpen G, Mowat M, Greenberg AH, Turley EA: Cloning and characterization of the gene encoding the hyaluronan receptor RHAMM: The role of a secreted isoform in the regulation of focal adhesion formation. Gene (in press)
44. Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA: Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 82:19, 1995
45. Caligaris-Cappio F, Bergui L, Gregorett MG, Gaidano G, Gaboli M, Schena M, Zallone AZ, Marchisio PC: Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77:2688, 1991
46. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A: Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487, 1995